In vitro and in ovo studies demonstrate that hydroxyapatite-quercetin composites reduce oxidative stress and enhance fibroblast migration.
Hydroxyapatite (HaP) is a biomaterial valued for its biocompatibility and osteoconductive properties, making it suitable for implantology and tissue engineering. The natural flavonoid quercetin (Q) exhibits potent antioxidant and anti-inflammatory effects that support wound healing and reduce oxidative stress. This study assessed the combined impact of HaP and Q on fibroblast viability, oxidative stress markers, and cell migration. The in ovo model evaluated systemic effects via morphometric parameters and oxidative stress in embryonic liver tissue.Results show that Q significantly decreased oxidative stress by increasing antioxidant enzyme activity and reducing intracellular ROS levels in fibroblasts and embryonic liver (p < 0.05). HaP alone induced a mild pro-oxidant response, but its combination with Q (QHaP) led to a marked reduction in oxidative stress markers, indicating a protective synergistic effect. Scratch assay revealed that Q and QHaP enhanced fibroblast migration at all concentrations, with HaP10 showing the highest wound closure (93.8%) and QHaP10 reaching 89.9% (p < 0.05). The in ovo model confirmed that QHaP-treated embryos developed normally, while Q improved embryonic antioxidant defenses. These findings suggest that QHaP composites are promising biocompatible materials that reduce oxidative stress and promote fibroblast migration for wound healing and tissue regeneration.
No takes yet. Share an insight, caveat, or question.
Bień et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: